Is ASIX or CC more profitable?

AdvanSix has a net margin of 0.67% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets AdvanSix 0.67% 2.18% 1.05% Chemours -6.82% 52.49% 1.78%

Is CE or CC more profitable?

Chemours has a net margin of -6.82% compared to Celanese's net margin of -11.54%. Chemours' return on equity of 52.49% beat Celanese's return on equity. Company Net Margins Return on Equity Return on Assets Celanese -11.54% 9.92% 2.12% Chemours -6.82% 52.49% 1.78%

Which has better valuation and earnings, DOW or CC?

Chemours has lower revenue, but higher earnings than DOW. DOW is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DOW $39.97B 0.61 -$2.62B -$3.99 N/A Chemours $5.81B 0.57 -$386M -$2.64 N/A

Is DOW or CC more profitable?

Chemours has a net margin of -6.82% compared to DOW's net margin of -7.24%. Chemours' return on equity of 52.49% beat DOW's return on equity. Company Net Margins Return on Equity Return on Assets DOW -7.24% -4.29% -1.29% Chemours -6.82% 52.49% 1.78%

Is HUN or CC more profitable?

Huntsman has a net margin of -5.83% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Huntsman's return on equity. Company Net Margins Return on Equity Return on Assets Huntsman -5.83% -4.60% -1.93% Chemours -6.82% 52.49% 1.78%

Chemours (CC) Competitors

$22.16 -0.56 (-2.44%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$22.15 -0.02 (-0.07%)

As of 05/29/2026 07:49 PM Eastern

Compare

CC vs. ASIX, CE, DOW, EMN, and HUN

Should you buy Chemours stock or one of its competitors? MarketBeat compares Chemours with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Chemours include AdvanSix (ASIX), Celanese (CE), DOW (DOW), Eastman Chemical (EMN), and Huntsman (HUN). These companies are all part of the "basic materials" sector.

How does Chemours compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Chemours (NYSE:CC) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

AdvanSix has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.52B	0.40	$49.29M	$0.37	60.59
Chemours	$5.81B	0.57	-$386M	-$2.64	N/A

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -13.3% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

AdvanSix presently has a consensus price target of $22.50, indicating a potential upside of 0.36%. Chemours has a consensus price target of $24.60, indicating a potential upside of 10.99%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than AdvanSix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

AdvanSix has a beta of 1.28, indicating that its share price is 28% more volatile than the broader market. Comparatively, Chemours has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

86.4% of AdvanSix shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 5.0% of AdvanSix shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

AdvanSix has a net margin of 0.67% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
Chemours	-6.82%	52.49%	1.78%

In the previous week, AdvanSix's average media sentiment score of 0.00 equaled Chemours'average media sentiment score.

Company	Overall Sentiment
AdvanSix	Neutral
Chemours	Neutral

Summary

Chemours beats AdvanSix on 9 of the 17 factors compared between the two stocks.

How does Chemours compare to Celanese?

Celanese (NYSE:CE) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

In the previous week, Celanese had 12 more articles in the media than Chemours. MarketBeat recorded 12 mentions for Celanese and 0 mentions for Chemours. Celanese's average media sentiment score of 0.33 beat Chemours' score of 0.00 indicating that Celanese is being referred to more favorably in the media.

Company	Overall Sentiment
Celanese	Neutral
Chemours	Neutral

Chemours has a net margin of -6.82% compared to Celanese's net margin of -11.54%. Chemours' return on equity of 52.49% beat Celanese's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celanese	-11.54%	9.92%	2.12%
Chemours	-6.82%	52.49%	1.78%

98.9% of Celanese shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.3% of Celanese shares are held by insiders. Comparatively, 0.9% of Chemours shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Celanese presently has a consensus target price of $67.81, suggesting a potential upside of 27.70%. Chemours has a consensus target price of $24.60, suggesting a potential upside of 10.99%. Given Celanese's stronger consensus rating and higher probable upside, equities research analysts clearly believe Celanese is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celanese	1 Sell rating(s)	7 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.50
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

Chemours has lower revenue, but higher earnings than Celanese. Chemours is trading at a lower price-to-earnings ratio than Celanese, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celanese	$9.54B	0.61	-$1.17B	-$10.01	N/A
Chemours	$5.81B	0.57	-$386M	-$2.64	N/A

Celanese has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Chemours has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Celanese pays out -1.2% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Celanese beats Chemours on 10 of the 18 factors compared between the two stocks.

How does Chemours compare to DOW?

DOW (NYSE:DOW) and Chemours (NYSE:CC) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

Chemours has lower revenue, but higher earnings than DOW. DOW is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DOW	$39.97B	0.61	-$2.62B	-$3.99	N/A
Chemours	$5.81B	0.57	-$386M	-$2.64	N/A

In the previous week, DOW had 6 more articles in the media than Chemours. MarketBeat recorded 6 mentions for DOW and 0 mentions for Chemours. DOW's average media sentiment score of 0.77 beat Chemours' score of 0.00 indicating that DOW is being referred to more favorably in the media.

Company	Overall Sentiment
DOW	Positive
Chemours	Neutral

DOW presently has a consensus target price of $40.94, indicating a potential upside of 21.19%. Chemours has a consensus target price of $24.60, indicating a potential upside of 10.99%. Given DOW's stronger consensus rating and higher possible upside, research analysts clearly believe DOW is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DOW	2 Sell rating(s)	8 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.55
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

Chemours has a net margin of -6.82% compared to DOW's net margin of -7.24%. Chemours' return on equity of 52.49% beat DOW's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DOW	-7.24%	-4.29%	-1.29%
Chemours	-6.82%	52.49%	1.78%

DOW pays an annual dividend of $1.40 per share and has a dividend yield of 4.1%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. DOW pays out -35.1% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DOW is clearly the better dividend stock, given its higher yield and lower payout ratio.

DOW has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Chemours has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

64.0% of DOW shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.5% of DOW shares are held by company insiders. Comparatively, 0.9% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

DOW beats Chemours on 10 of the 19 factors compared between the two stocks.

How does Chemours compare to Eastman Chemical?

Chemours (NYSE:CC) and Eastman Chemical (NYSE:EMN) are both mid-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Chemours has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, Eastman Chemical has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market.

In the previous week, Eastman Chemical had 2 more articles in the media than Chemours. MarketBeat recorded 2 mentions for Eastman Chemical and 0 mentions for Chemours. Eastman Chemical's average media sentiment score of 0.33 beat Chemours' score of 0.00 indicating that Eastman Chemical is being referred to more favorably in the news media.

Company	Overall Sentiment
Chemours	Neutral
Eastman Chemical	Neutral

76.3% of Chemours shares are held by institutional investors. Comparatively, 83.7% of Eastman Chemical shares are held by institutional investors. 0.9% of Chemours shares are held by insiders. Comparatively, 2.6% of Eastman Chemical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Eastman Chemical has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.57	-$386M	-$2.64	N/A
Eastman Chemical	$8.75B	0.99	$474M	$3.45	22.00

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 4.4%. Chemours pays out -13.3% of its earnings in the form of a dividend. Eastman Chemical pays out 97.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Eastman Chemical has raised its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Eastman Chemical has a net margin of 4.62% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-6.82%	52.49%	1.78%
Eastman Chemical	4.62%	8.88%	3.52%

Chemours presently has a consensus target price of $24.60, suggesting a potential upside of 10.99%. Eastman Chemical has a consensus target price of $80.25, suggesting a potential upside of 5.74%. Given Chemours' higher probable upside, equities research analysts plainly believe Chemours is more favorable than Eastman Chemical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Eastman Chemical	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Eastman Chemical beats Chemours on 15 of the 19 factors compared between the two stocks.

How does Chemours compare to Huntsman?

Huntsman (NYSE:HUN) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Huntsman pays an annual dividend of $0.35 per share and has a dividend yield of 2.3%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Huntsman pays out -18.2% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has raised its dividend for 4 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Huntsman has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Huntsman, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huntsman	$5.68B	0.47	-$284M	-$1.92	N/A
Chemours	$5.81B	0.57	-$386M	-$2.64	N/A

Huntsman has a net margin of -5.83% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Huntsman's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huntsman	-5.83%	-4.60%	-1.93%
Chemours	-6.82%	52.49%	1.78%

Huntsman presently has a consensus target price of $13.17, suggesting a potential downside of 14.37%. Chemours has a consensus target price of $24.60, suggesting a potential upside of 10.99%. Given Chemours' stronger consensus rating and higher probable upside, analysts plainly believe Chemours is more favorable than Huntsman.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huntsman	4 Sell rating(s)	9 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.93
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

84.8% of Huntsman shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 6.8% of Huntsman shares are held by company insiders. Comparatively, 0.9% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Huntsman had 2 more articles in the media than Chemours. MarketBeat recorded 2 mentions for Huntsman and 0 mentions for Chemours. Huntsman's average media sentiment score of 1.10 beat Chemours' score of 0.00 indicating that Huntsman is being referred to more favorably in the media.

Company	Overall Sentiment
Huntsman	Positive
Chemours	Neutral

Huntsman has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Chemours has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market.

Summary

Huntsman beats Chemours on 12 of the 20 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CC vs. The Competition

Export

Metric	Chemours	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$3.33B	$13.75B	$4.97B	$23.19B
Dividend Yield	1.58%	2.15%	4.94%	4.09%
P/E Ratio	-8.40	37.46	22.96	27.79
Price / Sales	0.57	2.23	6,553.59	24.75
Price / Cash	6.72	12.53	24.41	19.43
Price / Book	13.27	2.02	9.58	4.70
Net Income	-$386M	$162.94M	$156.62M	$1.07B
7 Day Performance	3.70%	4.35%	2.41%	1.14%
1 Month Performance	-17.85%	5.14%	2.30%	1.26%
1 Year Performance	118.37%	42.84%	77.13%	28.06%

Chemours Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CC Chemours	2.8027 of 5 stars	$22.17 -2.4%	$24.60 +11.0%	+118.4%	$3.33B	$5.81B	N/A	5,700
ASIX AdvanSix	2.3257 of 5 stars	$21.77 +0.7%	$25.67 +17.9%	-4.7%	$582.85M	$1.52B	58.85	1,410
CE Celanese	4.3957 of 5 stars	$55.74 -1.9%	$67.81 +21.7%	+0.5%	$6.23B	$9.54B	N/A	11,434	Analyst Forecast Analyst Revision
DOW DOW	4.3543 of 5 stars	$38.56 -0.5%	$41.33 +7.2%	+21.7%	$27.93B	$39.97B	N/A	34,600	News Coverage Analyst Forecast
EMN Eastman Chemical	4.2074 of 5 stars	$70.90 -1.0%	$80.25 +13.2%	-3.1%	$8.19B	$8.75B	20.55	13,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CC) was last updated on 5/31/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Competitors